DISCOVERY: prevalence of transthyretin (TTR) mutations in a US-centric patient population suspected of having cardiac amyloidosis: a comment
Amyloid
.
2021 Jun;28(2):134-135.
doi: 10.1080/13506129.2020.1830272.
Epub 2020 Oct 12.
Authors
Ana Roteta Unceta Barrenechea
1
2
,
Carmen Lahuerta Pueyo
3
2
,
Jorge Melero Polo
4
2
,
Sebastián Menao Guillén
3
2
,
Alejandro Andrés Gracia
1
2
,
Pablo Revilla Marti
4
2
,
Miguel Ángel Aibar Arregui
5
2
Affiliations
1
Department of Nuclear Medicine (UCMHMNA), Hospital Clínico Universitario de Zaragoza (HCUZ), Aragón, Spain.
2
IIS-Aragón, Zaragoza, Spain.
3
Department of Clinical Biochemistry, Hospital Clínico Universitario de Zaragoza (HCUZ), Aragon, Spain.
4
Department of Cardiology, Hospital Clínico Universitario de Zaragoza (HCUZ), Aragon, Spain.
5
Department of Internal Medicine, Hospital Clínico Universitario de Zaragoza (HCUZ), Aragon, Spain.
PMID:
33043707
DOI:
10.1080/13506129.2020.1830272
No abstract available
Publication types
Letter
Comment
MeSH terms
Amyloid Neuropathies, Familial* / genetics
Humans
Mutation
Prealbumin* / genetics
Prevalence
Substances
Prealbumin